Lv5
970 积分 2024-07-23 加入
The LNCaP cell line--a new model for studies on human prostatic carcinoma
4个月前
已关闭
RORγt Inhibition Reduces Pro-Tumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer
5个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
5个月前
已完结
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer
6个月前
已完结
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
6个月前
已完结
Interactions governing transcriptional activity of nuclear receptors
7个月前
已关闭
From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation
8个月前
已完结
Conquering PROTAC molecular design and drugability
8个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
8个月前
已完结
Vepdegestrant for the treatment of HR+/HER2– breast cancer
8个月前
已完结
Small Molecules Targeting the Transmembrane Domain
6个月前
已采纳
Metal/Oxide Interface Enabling Selective Electrocatalytic Reduction of Oxime to Amine in Neutral Electrolyte
6个月前
已采纳
Discovery of CaSR Peptide Agonists via Multistage Screening: In Silico Design, In Vitro Validation, and In Vivo Efficacy
7个月前
已采纳
皖公网安备34019202002308
